Similar Articles
21 Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management
22 Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
23 Splenectomy and risk of hepatocellular carcinoma
24 Link between type 2 diabetes mellitus and hepatocellular carcinoma
25 Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis
26 Lifestyle factors in hepatocellular carcinoma: From pathogenesis to prognosis
27 Radiofrequency ablation of liver metastases in a patient with pancreatic cancer and long-term survival: A case report
28 Imaging-pathology correlation in pancreatic cancer: Methodological considerations and future directions
29 Flap endonuclease-1 promotes pancreatic cancer progression via AKT/mTOR signaling pathway
30 Resveratrol: A promising agent in targeting senescent cancer-associated fibroblasts to inhibit pancreatic cancer progression
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA